Quantitative Assessment of Systemic Sclerosis–Related Interstitial Lung Disease via 3D ‐Imaging
Respirology · 2025-07 · 30 (7) · 652-661
DOI: 10.1111/resp.70024 ↗Kurz gefasst
Fachartikel in der Zeitschrift Respirology, online erschienen am 17.03.2025. Verfasst von Hiromasa Nakayasu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan. Hauptthemen laut MEDLINE: Lung Diseases, Interstitial, Scleroderma, Systemic, Imaging, Three-Dimensional, Lung. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science, Hamamatsu University School of Medicine.
Abstract (Originalsprache)
Background and Objective Interstitial lung disease (ILD) is a leading cause of morbidity and mortality in patients with systemic sclerosis (SSc). The disease course of SSc‐related ILD (SSc‐ILD) is heterogeneous, and several risk‐based models have been developed. This study aimed to quantitatively measure volume loss and disease extent and subsequently evaluate their associations with the development of end‐stage lung disease (ESLD).
Methods
Lung volume (LV) and disease extent were retrospectively and quantitatively evaluated in two cohorts (exploratory: n = 70; validation: n = 42) using high‐resolution computed tomography at the time of SSc‐ILD diagnosis, compared to controls ( n = 70). LV was quantitatively measured using three‐dimensional imaging (3D‐image) and standardised by predicted forced vital capacity (standardised LV). The ratio of the normally attenuated LV (range, −950 to −750 Hounsfield units) to the whole‐LV (NL%) was also measured using 3D‐image. The associations of these variables with ESLD were evaluated.
Results
Volume loss and normal lung area loss were noted in patients with SSc‐ILD compared with controls, especially in the lower lobes. Meanwhile, extended ILD lesions without volume reduction were observed in the upper lobes. Both decreased standardised LV and NL% were associated with ESLD development, and age and NL% were significant risk factors for ESLD independent of pulmonary function test parameters and standardised LV. A composite model consisting of age and NL% successfully stratified patients with SSc‐ILD based on the risk of ESLD.
Conclusion
3D‐image may be a useful technique for assessing disease severity and predicting the risk for ESLD in patients with SSc‐ILD. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan.
- Department of Respiratory Medicine, Seirei-Hamamatsu General Hospital, Hamamatsu, Japan.
- Department of Respiratory Medicine, Seirei-Mikatahara General Hospital, Hamamatsu, Japan.
ORCID-Profile: Yuzo Suzuki, Masato Kono, Hideki Yasui, Hironao Hozumi, Masato Karayama, Noriyuki Enomoto, Tomoyuki Fujisawa, Naoki Inui
Förderung
- Japan Society for the Promotion of Science
- Hamamatsu University School of Medicine
Zitieren
APA
Nakayasu, H., Suzuki, Y., Kono, M., Hashimoto, D., Kato, S., Yokomura, K., Inoue, Y., Yasui, H., Hozumi, H., Karayama, M., Furuhashi, K., Enomoto, N., Fujisawa, T., Inui, N., & Suda, T. (2025). Quantitative Assessment of Systemic Sclerosis–Related Interstitial Lung Disease via 3D ‐Imaging. Respirology, 30(7), 652-661. https://doi.org/10.1111/resp.70024
Vancouver
Nakayasu H, Suzuki Y, Kono M, Hashimoto D, Kato S, Yokomura K, et al. Quantitative Assessment of Systemic Sclerosis–Related Interstitial Lung Disease via 3D ‐Imaging. Respirology. 2025;30(7):652-661. doi:10.1111/resp.70024
BibTeX
@article{Nakayasu2025,
author = {Nakayasu, Hiromasa and Suzuki, Yuzo and Kono, Masato and Hashimoto, Dai and Kato, Shinpei and Yokomura, Koshi and Inoue, Yusuke and Yasui, Hideki and Hozumi, Hironao and Karayama, Masato and Furuhashi, Kazuki and Enomoto, Noriyuki and Fujisawa, Tomoyuki and Inui, Naoki and Suda, Takafumi},
title = {Quantitative Assessment of Systemic Sclerosis–Related Interstitial Lung Disease via 3D ‐Imaging},
journal = {Respirology},
year = {2025},
volume = {30},
number = {7},
pages = {652--661},
doi = {10.1111/resp.70024}
}
EUVIMED